Column Group Ii, Lp - Net Worth and Insider Trading

Column Group Ii, Lp Net Worth

The estimated net worth of Column Group Ii, Lp is at least $35 Million dollars as of 2024-04-24. Column Group Ii, Lp is the 10% Owner of RAPT Therapeutics Inc and owns about 4,425,439 shares of RAPT Therapeutics Inc (RAPT) stock worth over $35 Million. Details can be seen in Column Group Ii, Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Column Group Ii, Lp has not made any transactions after 2022-05-25 and currently still holds the listed stock(s).

Transaction Summary of Column Group Ii, Lp

To

Column Group Ii, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Column Group Ii, Lp owns 8 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .

Click here to see the complete history of Column Group Ii, Lp’s form 4 insider trades.

Insider Ownership Summary of Column Group Ii, Lp

Ticker Comapny Transaction Date Type of Owner
RAPT RAPT Therapeutics Inc 2022-05-25 10 percent owner
NGM NGM Biopharmaceuticals Inc 2019-04-03 10 percent owner
NRIX Nurix Therapeutics Inc 2021-05-07 10 percent owner
ORIC ORIC Pharmaceuticals Inc 2021-11-12 10 percent owner
IMDZ Immune Design Corp 2019-04-02 10 percent owner
GRTS Gritstone Bio Inc 2018-09-27 10 percent owner
RCUS Arcus Biosciences Inc 2018-03-14 10 percent owner
EFTR eFFECTOR Therapeutics Inc 2021-08-25 10 percent owner

Column Group Ii, Lp Latest Holdings Summary

Column Group Ii, Lp currently owns a total of 1 stock. Column Group Ii, Lp owns 4,425,439 shares of RAPT Therapeutics Inc (RAPT) as of May 25, 2022, with a value of $35 Million.

Latest Holdings of Column Group Ii, Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RAPT RAPT Therapeutics Inc 2022-05-25 4,425,439 7.90 34,960,968

Holding Weightings of Column Group Ii, Lp


Column Group Ii, Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Column Group Ii, Lp has made a total of 14 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 7 buys and 7 sells. The most-recent trade in RAPT Therapeutics Inc is the acquisition of 1,900 shares on May 25, 2022, which cost Column Group Ii, Lp around $23,655.

Insider Trading History of Column Group Ii, Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Column Group Ii, Lp Trading Performance

GuruFocus tracks the stock performance after each of Column Group Ii, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Column Group Ii, Lp is 141.07%. GuruFocus also compares Column Group Ii, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Column Group Ii, Lp within 3 months outperforms 7 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Column Group Ii, Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Column Group Ii, Lp

Average Return

76.97%

Average return per transaction

Outperforming Transactions

100%

7 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 56.05 141.07 52.67 76.97 77.81 18.45
Relative Return to S&P 500(%) 57.3 135.53 53.12 71.8 54.54 11.46

Column Group Ii, Lp Ownership Network

Ownership Network List of Column Group Ii, Lp

No Data

Ownership Network Relation of Column Group Ii, Lp


Column Group Ii, Lp Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Column Group Ii, Lp is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Tcg Iv Gp, Llc .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, Column Group Ii, Lp made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 44,000 shares made by William Ho , a net sale of 1,640 shares made by Dirk G. Brockstedt , and a net purchase of 5,000 shares made by Wendye Robbins .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,640 shares of RAPT Therapeutics Inc (RAPT) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 40,640 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RAPT Therapeutics Inc Insider Transactions

No Available Data

Column Group Ii, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Column Group Ii, Lp. You might contact Column Group Ii, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Discussions on Column Group Ii, Lp

No discussions yet.